Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Recalled Darvon and Darvocet Pain Killers Were Commonly Prescribed to Surgery Patients

(EMAILWIRE.COM, December 23, 2010 ) New York, NY – Recently pulled from the market, Darvon and Darvocet prescription pain relievers were commonly prescribed to patients undergoing surgery, including cosmetic, knee and dental procedures. Darvon and Darvocet contained the active ingredient propoxyphene, a relatively weak narcotic designed to treat mild to moderate pain. As of Nov. 2010, however, the FDA decided that propoxyphene’s pain relief benefits no longer outweighed its risks, which include abnormal heart rhythms and fatal overdose, and requested that a Darvon and Darvocet recall be issued. As As a result of this action, patients who used propoxyphene and suffered from Darvon or Darvocet side effects may be entitled to financial compensation. Visit http://www.classaction.org/darvon-and-darvocet.html and complete the free case evaluation form to find out if you can participate in a Darvon class action lawsuit.

Darvon and Darvocet work to relieve pain by acting on the central nervous system, rather than directly at the site of pain. Both recalled propoxyphene products were prescribed for long-term and short-term pain, including the discomfort experienced following a surgical procedure. Darvon was helpful in certain individuals, including those allergic to acetaminophen, while Darvocet aimed to maximize pain relief benefits in users, as it contained both propoxyphene and acetaminophen.

The drugs, however, were not without side effects. Darvon and Darvocet received a black box warning in 2009 to highlight the risk of fatal overdoses, both accidental and intentional (suicide), in patients taking large doses and/or propoxyphene in combination with alcohol or central nervous system depressants. Most recently, Darvon and Darvocet were part of a propoxyphene recall; this was issued after the FDA reviewed a study which indicated that, even when taken in recommended dosages, propoxyphene can dangerously interact with the electrical activity of the heart.

Patients who have experienced Darvon heart problems, as well as family members who lost loved ones due to a Darvocet suicide, overdose or sudden cardiac death, may have legal recourse. The Darvon attorneys working with Class Action.org are offering a free legal evaluation to anyone affected by the serious side effects of propoxyphene. To receive your free case review, visit Class Action.org today.

About Class Action.org

Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.


ClassAction.org
Tara Nagel
800-449-1970
pressrelease@lawyercentral.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC